Pharmaceutical drugs supplied by: TAGI Pharma, Inc.
✉ Email this page to a colleague
TAGI Pharma, Inc.
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
---|---|---|---|---|---|---|---|---|---|
Cspc-nbp Pharm | BENZONATATE | benzonatate | CAPSULE;ORAL | 202765 | ANDA | TAGI Pharma, Inc. | 51224-001-50 | 100 CAPSULE in 1 BOTTLE (51224-001-50) | 2015-08-10 |
Cspc-nbp Pharm | BENZONATATE | benzonatate | CAPSULE;ORAL | 202765 | ANDA | TAGI Pharma, Inc. | 51224-001-60 | 500 CAPSULE in 1 BOTTLE (51224-001-60) | 2015-08-10 |
Cspc Ouyi | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 078321 | ANDA | TAGI Pharma, Inc. | 51224-007-50 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51224-007-50) | 2008-04-17 |
Cspc Ouyi | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 078321 | ANDA | TAGI Pharma, Inc. | 51224-007-60 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (51224-007-60) | 2008-04-17 |
Cspc Ouyi | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 078321 | ANDA | TAGI Pharma, Inc. | 51224-007-70 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51224-007-70) | 2008-04-17 |
Tagi | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 209599 | ANDA | TAGI Pharma, Inc. | 51224-009-10 | 201.6 g in 1 CAN (51224-009-10) | 2020-11-12 |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |